Skip to content

A Multi-center, Blinding, single-arm, Retrospective Pivotal Clinical Trial to evaluate the effectiveness of AI Gatekeeper, an artificial intelligence (AI)-based analysis software that aids in coronary artery disease screening

A Multi-center, Blinding, single-arm, Retrospective Pivotal Clinical Trial to evaluate the effectiveness of AI Gatekeeper, an artificial intelligence (AI)-based analysis software that aids in coronary artery disease screening

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CRIS
Registry ID
KCT0008516
Enrollment
544
Registered
2023-06-12
Start date
2023-06-21
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The reading and analysis of the test device (AI-Gatekeeper) is carried out simultaneously with the reference standard verification and confirmation process under the supervision of th

Sponsors

Infinitt Healthcare
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Data of patients aged 19 years or older 2. During the period prior to IRB approval, patients visited the circulatory outpatient department with symptoms such as chest pain suspected of having coronary artery disease, and received general medical examinations and standard tests such as blood tests, electrocardiograms, chest X-rays, echocardiography, and invasive angiography. Data of patients who were finally diagnosed with coronary artery disease by performing A. Positive data: data of patients with diameter stenosis = 50% B. Negative data: data of patients with coronary artery diameter stenosis < 50%

Exclusion criteria

Exclusion criteria: 1. Data of patients who did not satisfy the test subject selection criteria (including missing values) 2. Data of patients who have already been diagnosed with coronary artery disease or who have undergone coronary artery revascularization. 3. Data of patients without basic data such as blood test, electrocardiogram and chest X-ray imaging test, echocardiography, etc. available within 1 year before coronary angiography, which is a confirmatory test 4. Data of patients who took cardiovascular disease drugs that have an effect on coronary artery vascular blockage under the judgment of other clinicians

Design outcomes

Primary

MeasureTime frame
Based on the reference standard, the estimated sensitivity and specificity for the diameter stenosis = 50% classification of the test device (AI-Gatekeeper) are 70% and 75% or more, respectively, and the minimum sensitivity and specificity as the lower limit of the confidence interval are clinically effective at 61% and 66% or more, respectively.

Secondary

MeasureTime frame
Coronary artery stenosis of test device (AI Gatekeeper) based on reference standard (diameter stenosis) Check the AUC for the = 50% division.

Countries

Korea, Republic of

Contacts

Public ContactIn Hyun Jung

Yonsei University Yongin Severance Hospital

saveheart@yuhs.ac+82-31-5189-9659

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026